Johan Wäborg
Chief Executive Officer chez ICONOVO AB
Fortune : 36 750 $ au 31/03/2024
Profil
Johan Wäborg is currently the Chief Executive Officer at Iconovo AB.
He is also a Director and Owner at Phigalia AB, JWsquared AB, and Wsquared AB.
Previously, he was the Regional Director-Business Support at Actelion Ltd.
and the General Manager at Actelion Pharmaceuticals Sverige AB and Marklas Nederland BV.
He obtained his undergraduate degree from the Swiss Federal Institute of Technology and his graduate degree from the Faculty of Engineering, Lund University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ICONOVO AB
0,39% | 21/09/2022 | 45 586 ( 0,39% ) | 36 750 $ | 31/03/2024 |
Postes actifs de Johan Wäborg
Sociétés | Poste | Début |
---|---|---|
ICONOVO AB | Chief Executive Officer | 14/04/2020 |
Phigalia AB
Phigalia AB Food DistributorsDistribution Services Phigalia AB is a Swedish company that wholesales beverages. The private company is based in Skane, Sweden. | Director/Board Member | - |
JWsquared AB | Director/Board Member | - |
Wsquared AB | Director/Board Member | - |
Anciens postes connus de Johan Wäborg
Sociétés | Poste | Fin |
---|---|---|
Actelion Pharmaceuticals Sverige AB
Actelion Pharmaceuticals Sverige AB Pharmaceuticals: MajorHealth Technology Actelion Pharmaceuticals Sverige AB conducts research, development, manufacture, and trade and marketing of pharmaceutical and medical products. The firm wholesales medical equipment and pharmaceutical medicine. It also develops and markets new drugs in the therapeutic areas of pulmonary arterial hypertension. The company founded in 2002 and is headquartered in Danderyd, Sweden. | Chief Executive Officer | 01/04/2020 |
Marklas Nederland BV | Corporate Officer/Principal | - |
ACTELION | Corporate Officer/Principal | - |
Actelion Pharmaceuticals Sverige AB
Actelion Pharmaceuticals Sverige AB Pharmaceuticals: MajorHealth Technology Actelion Pharmaceuticals Sverige AB conducts research, development, manufacture, and trade and marketing of pharmaceutical and medical products. The firm wholesales medical equipment and pharmaceutical medicine. It also develops and markets new drugs in the therapeutic areas of pulmonary arterial hypertension. The company founded in 2002 and is headquartered in Danderyd, Sweden. | Corporate Officer/Principal | - |
Formation de Johan Wäborg
Swiss Federal Institute of Technology | Undergraduate Degree |
Faculty of Engineering, Lund University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ICONOVO AB | Health Technology |
Entreprise privées | 6 |
---|---|
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
Actelion Pharmaceuticals Sverige AB
Actelion Pharmaceuticals Sverige AB Pharmaceuticals: MajorHealth Technology Actelion Pharmaceuticals Sverige AB conducts research, development, manufacture, and trade and marketing of pharmaceutical and medical products. The firm wholesales medical equipment and pharmaceutical medicine. It also develops and markets new drugs in the therapeutic areas of pulmonary arterial hypertension. The company founded in 2002 and is headquartered in Danderyd, Sweden. | Health Technology |
Phigalia AB
Phigalia AB Food DistributorsDistribution Services Phigalia AB is a Swedish company that wholesales beverages. The private company is based in Skane, Sweden. | Distribution Services |
Marklas Nederland BV | Distribution Services |
JWsquared AB | |
Wsquared AB |